On Tuesday, March 11 at 11 am, The Capitol Forum will host Shweta Kumar to discuss legal considerations for companies that compound GLP-1 weight-loss drugs as these blockbuster products start to come off shortage.
To attend the call, you must provide a business email address. Registrations with a personal address will be denied.*
If you need assistance accessing the link, please email info@thecapitolforum-news.com.
Join us to learn more about:
Shweta Kumar Bio
Shweta Kumar is a clinical teaching fellow in the Intellectual Property and Information Policy Clinic at Georgetown University, where she focuses on pharmaceutical, patent and FDA law as well as health privacy and patient access. She has published research on the patent litigation risk faced by drug compounders and the intersection of FDA and patent law when it comes to pharmaceutical compounding.
Previously, Kumar worked as an intellectual property lawyer at Goodwin Procter LLP, representing clients across a range of industries. She also served as a legal extern at the Intellectual Property Section of the Department of Justice.
Kumar earned her J.D. from UVA Law and a B.S. in Neuroscience from the College of William & Mary.
Shweta Kumar
Clinical Teaching Fellow in the Intellectual Property and Information Policy Clinic, Georgetown University
Alice Tracey
Correspondent, The Capitol Forum
